Bridgefront Capital’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $286K | Sell |
49,901
-619
| -1% | -$3.55K | 0.08% | 444 |
|
|
2025
Q1 | $412K | Buy |
50,520
+2,780
| +6% | +$22.7K | 0.12% | 312 |
|
|
2024
Q4 | $450K | Buy |
47,740
+11,042
| +30% | +$104K | 0.15% | 232 |
|
|
2024
Q3 | $392K | Buy |
36,698
+25,715
| +234% | +$275K | 0.15% | 253 |
|
|
2024
Q2 | $109K | Buy |
+10,983
| New | +$109K | 0.05% | 448 |
|
|
2023
Q2 | – | Sell |
-13,122
| Closed | -$146K | – | 540 |
|
|
2023
Q1 | $146K | Buy |
+13,122
| New | +$146K | 0.09% | 370 |
|
|
2021
Q3 | – | Sell |
-12,641
| Closed | -$122K | – | 462 |
|
|
2021
Q2 | $122K | Sell |
12,641
-16,739
| -57% | -$162K | 0.05% | 546 |
|
|
2021
Q1 | $290K | Buy |
29,380
+13,040
| +80% | +$129K | 0.09% | 438 |
|
|
2020
Q4 | $377K | Buy |
+16,340
| New | +$377K | 0.13% | 291 |
|